Antihyperglycemic effect of diosmin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats

Biomedicine and Pharmacotherapy

Volumn 64, Issue 7, 2010, Pages 477-481

  Pari, Leelavinothan ^a   Srinivasan, Subramani ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Diosmin; Glucose; Insulin; Streptozotocin

Indexed keywords

DIOSMIN; FRUCTOSE BISPHOSPHATASE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HEXOKINASE; INSULIN; LIVER ENZYME; NICOTINAMIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; DIABETES MELLITUS, EXPERIMENTAL; DIOSMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYMES; FRUCTOSE-BISPHOSPHATASE; GLUCOSE-6-PHOSPHATASE; GLUCOSEPHOSPHATE DEHYDROGENASE; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBINS; HYPOGLYCEMIC AGENTS; INSULIN; LIVER; MALE; NIACINAMIDE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 77956437923     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.02.001     Document Type: Article

References (47)

1. Harris M., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The third national and nutrition examination survey. Diabetes Care 1998, 21:518-526.
2. Kamtchouing P., Kahpui S.M., Djomeni Dzeufiet P.D., T'edong L., Asongalem E.A., Dimoa T. Anti-diabetic activity of methanol/methylene chloride stem bark extracts of Terminalia superba and Canarium schweinfurthii on streptozotocin-induced diabetic rats. J Ethnopharmacol 2006, 104:306-309.
3. Subash Babu P., Prabuseenivasan P., Ignacimuthu S. Cinnamaldehyde: a potential antidiabetic agent. Phytomedicine 2007, 14:15-22.
4. Schlyer S., Horuk R. I want a new drug: G-protein-coupled receptors in drug development. Drug Discov Today 2006, 11:481-493.
5. ®: evaluation of effects on quality of life in chronic venous insufficiency. M Angiology 2006, 57:131.
6. Campanero M.A., Escolar M., Perez, Garcia-Quetglas, Sadaba B., Azanza J.R. Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography - atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study. J Pharm Biomed Anal 2010, 51:875-881.
7. del Bano M.J., Lorente J., Castillo J., Benavente-Garcia O., Marin M.P., Del Rio J.A., et al. Flavonoid distribution during the development of leaves, flowers, stems, and roots of Rosmarinus officinalis. Postulation of a biosynthetic pathway. J Agric Food Chem 2004, 52:4987-4992.
8. Lorenzo C., Vita Di S., Sergio Fatta Del B., Schillaci D. Antiproliferative activity of citrus juices and HPLC evaluation of their flavonoid composition. Fitoterapia 2007, 78:426-429.
9. Le Marchand L., Murphy S.P., Hankin J.H., Wilkens L.R., Kolonel L.N., Natl J. Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000, 92:154-160.
10. Nogata Y., Sakamoto K., Shiratsuchi H., Ishii T., Yano M., Ohta H. Flavonoid composition of fruit tissues of citrus species. Biosci Biotechnol Biochem 2006, 70:178-192.
11. Erlund I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 2004, 24:851-874.
12. Hodek P., Trefil P., Stiborova M. Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 2002, 139:1-21.
13. Manuel Y., Keenoy B., Vertommen J., De Leeuw I. The effect of flavonoid treatment on the glycation and antioxidant status in type 1 diabetic patients. Diabetes Nutr Metab 1999, 12:256-263.
14. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998, 47:224-229.
15. Trinder P. Determination of glucose in blood using glucose oxidase with analternative oxygen acceptor. Ann Clin Biochem 1969, 6:24.
16. Bisse E., Abragam E.C. New less temperature sensitive, microchromato graphic method for the separation and quantitation of glycosylated haemoglobin using a non cyanide buffer system. J Chromatogr 1999, 344:81-91.
17. Brandstrup N., Kirk J.E., Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 1969, 12:166-171.
18. Koide H., Oda T. Pathological occurrence of glucose-6-phosphatase in serum in liver diseases. Clinica Chimica Acta 1959, 4:554-561.
19. Fiske C.H., Subbarow J. The colorimetric determination of phosphorous. J Biol Chem 1925, 66:375-400.
20. Gancedo J.M., Gancedo C. Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and nonfermenting yeasts. Arch Microbiol 1971, 76:132-138.
21. Lowry O.H., Rosenbrough N.J., Farr A.I., Randall R.J. Protein measurement with folin-phenol reagent. J Biol Chem 1951, 193:265.
22. Duncan B.D. Multiple range tests for correlated and heteroscedastic means. Biometrics 1957, 13:359-364.
23. King H., Aubert R.E., Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21. 1414-1431.
24. Sato J., Oshida Y., Yu M., Bajotto G., Sato Y. Effect of Gosha-jinki-gan (Chinese herbal medicine): (Niu-che-sen-qi-wan) on insulin resistance in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2003, 59:103-111.
25. Yolanda B.L., Adriana G.C. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. J Nutr Biochem 2006, 17:1-13.
26. Jantet G. Chronic venous insufficiency: worldwide results of the RELIEF Study. Angiology 2002, 53:245.
27. Labrid C. Pharmacologic properties of Daflon 500mg. Angiology 1994, 45:524-530.
28. Smith P.D., Neutrophil J. Activation and mediators of inflammation in chronic venous insufficiency. J Vasc Res 1999, 36:24.
29. Burns N, Gold B. The effect of 3-methyladenine DNA glycosylase-mediated DNA repair on the induction of toxicity and diabetes by the beta-cell toxicant streptozotocin. Toxicol Sci 2007, 95:391-400.
30. Roden M., Bernroider E. Hepatic glucose metabolism in humans-its role in health and disease. Best Pract Res Clin Endocrinol Metab 2003, 17:365-383.
31. Latner A. In: Clinical biochemistry. Philadelphia: Saunders; 1958. p. 48.
32. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper' biochemistry, twenty-fifth ed. Stanford, CT: Appleton and Lange; 2000.
33. Alberti KGMM, Press CM. The biochemistry and the complications of diabetes. In: Keen H, Jarrett J. (Eds.). Complications of diabetes 1982;43:231-70.
34. Paulsen EP. Haemoglobin A1c in childhood of diabetes. Pearse, AGE. Histochemistry-Theoretical and Applied, third ed. Churchill Livingstone 1981. Metabolism 1973;22:269-71.
35. Koeing R.J., Peterson C.M., Jones R.L., Saudek C., Lehman M., Cerami A. Correlation of glucose regulation and haemoglobin A1c in diabetes mellitus. N Engl J Med 1976, 295:417-420.
36. Gabbay K.H. Glycosylated haemoglobin and diabetic control. N Engl J Med 1976, 295:443-444.
37. Hikino H., Kobayashi M., Suzuki Y., Konno C. Mechanisms of hypoglycemic activity of aconitan A, a glycan from Aconitum carmichaeli roots. J Ethnopharmacol 1989, 25:295-304.
38. Ugochukwu N.H, Babady N.E. Antihyperglycemic effect of aqueous and ethanolic extracts of Gongronema latifolium leaves on glucose and glycogen metabolism in livers of normal and streptozotocin-induced diabetic rats. Life Sci 2003, 73:1925-1938.
39. Ashokkumar N., Pari L. Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 2005, 351:105-113.
40. Pari L., Satheesh M.A. Antidiabetic activity of Boerhaavia diffusa L. effect on hepatic key enzymes in experimental diabetes. J Ethnopharmacol 2004, 91:109-113.
41. Gupta D., Raju J., Prakash J.R., Baquer N.Z. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats, effect of insulin and vanadate. Diabetes Res Clin Pract 1999, 46:1-7.
42. Vats V., Yadav S.P., Grover J.K. Effect of Trigonella foenumgraecum on glycogen content of tissues and the 435 key enzymes of carbohydrate metabolism. J Ethnopharmacol 2003, 85:237-242.
43. Abdel-Rahim E.A., El-Saadany S.S., Abo-Eytta A.M., Wasif M.M. The effect of sammo administration on some fundamental enzymes of pentose phosphate pathway and energy metabolites of alloxanised rats. Nahrung 1992, 36:8-14.
44. Ugochukwu N.H., Babady N.E. Antidiabetic effects of Gongronema latifolium in hepatocyte of rat models of non-insulin dependent diabetes mellitus. Fitoterapia 2002, 73:612-618.
45. Berg JM, Tymoczko JL, Stryer L. Glycolysis and gluconeogenesis. In: Berg JM, Tymoczko JL, Stryer L (Eds.). Biochemistry. New York: WH Freeman and Company; 2001. p. 425-64.
46. Guignot L., Mithieux G. Mechanisms by which insulin, associated or not with glucose, may inhibit hepatic glucose production in the rate. Am J Physiol 1999, 277:984-989.
47. Baquer N.Z., Gupta D., Rajo J. Regulations of metabolic pathways in liver and kidney during experimental diabetes, Effect of antidiabetic compounds. Indian J Clin Biochem 1998, 3:63-80.